Jump to content

Search the hub

Showing results for tags 'Treatment'.

More search options

  • Search By Tags

    Start to type the tag you want to use, then select from the list.

  • Search By Author

Content Type


Forums

  • All
    • Commissioning, service provision and innovation in health and care
    • Coronavirus (COVID-19)
    • Culture
    • Improving patient safety
    • Investigations, risk management and legal issues
    • Leadership for patient safety
    • Organisations linked to patient safety (UK and beyond)
    • Patient engagement
    • Patient safety in health and care
    • Patient Safety Learning
    • Professionalising patient safety
    • Research, data and insight
    • Miscellaneous

Categories

  • Commissioning, service provision and innovation in health and care
    • Commissioning and funding patient safety
    • Digital health and care service provision
    • Health records and plans
    • Innovation programmes in health and care
    • Climate change/sustainability
  • Coronavirus (COVID-19)
    • Blogs
    • Data, research and statistics
    • Frontline insights during the pandemic
    • Good practice and useful resources
    • Guidance
    • Mental health
    • Exit strategies
    • Patient recovery
    • Questions around Government governance
  • Culture
    • Bullying and fear
    • Good practice
    • Occupational health and safety
    • Safety culture programmes
    • Second victim
    • Speak Up Guardians
    • Staff safety
    • Whistle blowing
  • Improving patient safety
    • Clinical governance and audits
    • Design for safety
    • Disasters averted/near misses
    • Equipment and facilities
    • Error traps
    • Health inequalities
    • Human factors (improving human performance in care delivery)
    • Improving systems of care
    • Implementation of improvements
    • International development and humanitarian
    • Safety stories
    • Stories from the front line
    • Workforce and resources
  • Investigations, risk management and legal issues
    • Investigations and complaints
    • Risk management and legal issues
  • Leadership for patient safety
    • Business case for patient safety
    • Boards
    • Clinical leadership
    • Exec teams
    • Inquiries
    • International reports
    • National/Governmental
    • Patient Safety Commissioner
    • Quality and safety reports
    • Techniques
    • Other
  • Organisations linked to patient safety (UK and beyond)
    • Government and ALB direction and guidance
    • International patient safety
    • Regulators and their regulations
  • Patient engagement
    • Consent and privacy
    • Harmed care patient pathways/post-incident pathways
    • How to engage for patient safety
    • Keeping patients safe
    • Patient-centred care
    • Patient Safety Partners
    • Patient stories
  • Patient safety in health and care
    • Care settings
    • Conditions
    • Diagnosis
    • High risk areas
    • Learning disabilities
    • Medication
    • Mental health
    • Men's health
    • Patient management
    • Social care
    • Transitions of care
    • Women's health
  • Patient Safety Learning
    • Patient Safety Learning campaigns
    • Patient Safety Learning documents
    • Patient Safety Standards
    • 2-minute Tuesdays
    • Patient Safety Learning Annual Conference 2019
    • Patient Safety Learning Annual Conference 2018
    • Patient Safety Learning Awards 2019
    • Patient Safety Learning Interviews
    • Patient Safety Learning webinars
  • Professionalising patient safety
    • Accreditation for patient safety
    • Competency framework
    • Medical students
    • Patient safety standards
    • Training & education
  • Research, data and insight
    • Data and insight
    • Research
  • Miscellaneous

News

  • News

Categories

  • Files

Calendars

  • Community Calendar

Find results in...

Find results that contain...


Date Created

  • Start
    End

Last updated

  • Start
    End

Filter by number of...

Joined

  • Start

    End

Group

First name

Last name

Country

Join a private group (if appropriate)

About me

Organisation

Role

Found 456 results
  1. News Article
    Thousands of people referred for urgent cancer checks every month are set to be diagnosed and treated sooner, as the NHS reforms its cancer standards to reflect what matters most to patients and to align with modern clinical practice. Developed by clinical experts and supported by leading cancer charities, there will be three cancer standards, which combine all of the previous standards and cover additional patients: the 28-Day Faster Diagnosis Standard (FDS) which means patients with suspected cancer who are referred for urgent cancer checks from a GP, screening programme or other route should be diagnosed or have cancer ruled out within 28 days. the 62-day referral to treatment standard which means patients who have been referred for suspected cancer from any source and go on to receive a diagnosis should start treatment within 62 days of their referral. the 31-day decision to treat to treatment standard which means patients who have a cancer diagnosis, and who have had a decision made on their first or subsequent treatment, should then start that treatment within 31 days. GPs will still refer people with suspected cancer in the same way, but the focus will rightly be on getting people diagnosed or cancer ruled out within 28 days, rather than simply getting a first appointment. The three agreed standards will come into effect from October. Read full story Source: NHS England, 17 August 2023
  2. News Article
    Despite regular MRI scans at the Royal Preston Hospital showing that the tumour was growing, May Ashford was not offered surgery until five years later. A woman died unnecessarily after doctors failed to operate soon enough on a growing brain tumour, according to the health complaints service. May Ashford, from Blackpool, was diagnosed with a brain tumour in 2010 after experiencing headaches and seizures. Despite regular MRI scans at the Royal Preston Hospital showing that the tumour was growing, she was not offered surgery until five years later. An investigation by the Parliamentary and Health Service Ombudsman (PHSO) said the treatment was too late as medical staff had failed to monitor the scan results properly. Medical experts said Mrs Ashford should have been operated on at least three years earlier, before the tumour had time to grow and affect the surrounding area of the brain. She tragically died aged 71 from a stroke following surgery. Link to full article here
  3. News Article
    More than 250,000 dementia patients could miss out on new treatments for the disease because they do not have a formal diagnosis, according to government figures. NHS data published for the first time shows the prevalence of different types of dementia with which people in England have been diagnosed. Dementia is an umbrella term for many different conditions, affecting more than 55 million people worldwide. This week, health regulators were urged to approve two new game-changing dementia drugs, after a landmark study confirmed that donanemab slowed cognitive decline in Alzheimer’s patients by 35%, while last year, a second drug, lecanemab, was found to reduce the rate by 27%. The NHS primary care dementia figures estimate that there are about 708,000 people over 65 with dementia in England, but only about 450,000 have a recorded diagnosis. That means that more than 250,000 are missing out on these potential new treatments. Read full story Source: The Guardian, 20 July 2023
  4. News Article
    More families have been told by a health board that their relatives' deaths may have been linked to treatment by vascular services. Betsi Cadwaladr University Health Board (BCUHB) has written to families who were part of a review after concerns were raised last year. Four cases had already been reported to a coroner and the health board says it has been "very open" with relatives of other patients. The service has recently been described by inspectors as making "satisfactory progress", but the health board admit it is still on a "long journey". A report by the Royal College of Surgeons England (RCSE) in January 2022 found risks to patient safety due, in part, to poor record keeping. It recommended to the health board that it investigate fully what happened to the 47 patients its report focused on. Read full story Source: BBC News, 13 July 2023
  5. News Article
    New guidance for doctors discouraging them from recommending exercise and cognitive behavioural therapy for chronic fatigue patients is not evidence based, according to researchers. A study questions the National Institute for Health and Care Excellence (NICE) review process for this guideline for clinicians dealing with chronic fatigue syndrome (CFS) and myalgic encephalomyelitis (ME) patients and its use of scientific standards in considering the evidence. One of the study’s lead authors, Prof Trudie Chalder from the psychiatry department at King’s College London said: “The decision to change the guideline has had a direct effect on doctors’ and therapists’ ability to treat patients. Services are no longer able to provide a full range of evidence-based therapeutic interventions. “This could have a devastating impact on people’s lives in that they will no longer be able to access the treatment that could help them the most.” ME, also called CFS, is a long-term condition believed to affect about 25,000 people in the UK, which has a wide range of symptoms including extreme tiredness, muscle pain, mental fogginess and insomnia. Read full story Source: The Guardian, 11 July 2023
  6. News Article
    A cancer patient has died and three others have been hospitalised after they were administered unlicensed versions of chemotherapy by Sciensus, a private company paid millions by the NHS to provide essential medication. Three health regulators have launched inquiries into the incident, according to people familiar with the matter. It was caused by an issue at the firm’s medicines manufacturing unit. In a statement, Sciensus confirmed an “isolated incident” had “affected four patients” and that it was “deeply saddened” that one of them had died. Sciensus offered its “sincere condolences” to the family and friends of the patient who died, and is conducting a thorough investigation, it added. The four patients received unlicensed versions of cabazitaxel, a licensed chemotherapy used to treat prostate cancer. The versions administered to the patients differed from the licensed product and therefore were considered unlicensed medicines. Sciensus is required to comply with official standards to ensure the quality of the products it produces and the protection of public health. Breaches of these standards can result in the MHRA suspending or removing a company’s licence. “Patient safety is our highest priority,” said Dr Alison Cave, the MHRA’s chief safety officer. “We are urgently investigating this issue and we will take any necessary regulatory measures to ensure patients are protected." Read full story Source: The Guardian, 7 July 2023
  7. News Article
    The number of people who die after a breast cancer diagnosis has decreased by two-thirds since the 1990s, a study of more than half a million women in England has shown. The research has taken ten years to complete, says Carolyn Taylor, lead author of the study and an oncologist at the University of Oxford, UK. The analysis includes the 512,447 women in England who were diagnosed with early invasive breast cancer between January 1993 and December 2015. The results published in the BMJ found women who were diagnosed in 1993–99 had a 14.4% risk of dying within 5 years. This fell to 4.9% for women diagnosed in 2010–15. Patient involvement was important to the study, Taylor says. The scientists appointed two patient representatives to guide their research. “They helped us in the questions to be addressed. They looked at the analyses and gave comments and suggestions throughout the study. And they helped us to interpret the results in the way that patients can understand.” Read full story Source: Nature, 23 June 2023
  8. News Article
    Many vulnerable patients are struggling to access covid treatments after commissioning responsibility switched to integrated care boards this week, charities have warned. Approximately two million vulnerable patients must now contact local services themselves to access treatments designed to combat covid infections, such as the antivirals Paxlovid and Sotrovimab. Integrated care boards are expected to coordinate and fund “equitable” access. Prior to 27 June, identification of patients and the delivery of treatment was coordinated nationally under pandemic arrangements. However, a group of 20 patient charities have written to Steve Barclay warning that most ICBs have not drawn up plans to deliver this new responsibility, leaving patients and primary care clinicians unclear on how to access the treatments. “Despite continually raising our concerns with those carrying out the planning, implementation, and communication of this [policy], we now find that we are in exactly the position we warned against,” they said. Read full story (paywalled) Source: HSJ, 3 July 2023
  9. News Article
    A new type of artificial-intelligence technology that cuts the time cancer patients must wait before starting radiotherapy is to be offered at cost price to all NHS trusts in England. It helps doctors calculate where to direct the therapeutic radiation beams, to kill cancerous cells while sparing as many healthy ones as possible. Researchers at Addenbrooke's Hospital trained the AI program with Microsoft. For each patient, doctors typically spend between 25 minutes and two hours working through about 100 scan cross-sections, carefully "contouring" or outlining bones and organs. But the AI program works two and a half times quicker, the researchers say. When treating the prostate gland, for example, medics want to avoid damage to the nearby bladder or rectum, which could leave patients with lifelong continence issues. Read full story Source: BBC News, 27 June 2023
  10. News Article
    At least 12,000 people were treated for sepsis in hospitals in Ireland last year, with one in five of those dying from the life-threatening condition. However, the HSE said the total number of cases is likely to be much higher. Marking World Sepsis Day, it said the condition kills more people each year than heart attacks, stroke or almost any cancer. The illness usually starts as a simple infection which leads to an “abnormal immune response” that can “overwhelm the patient and impair or destroy the function of any of the organs in the body”. Dr Michael O’Dwyer, the HSE’s sepsis clinical lead, said: “The most effective way to reduce deaths from sepsis is by prevention. “A healthy lifestyle with moderate exercise, good personal hygiene, good sanitation, breastfeeding when possible, avoiding unnecessary antibiotics and being vaccinated for preventable infections all play a role in preventing sepsis. “Early recognition and then seeking prompt treatment is key to survival. Recognising sepsis is notoriously difficult and the condition can progress rapidly over hours or sometimes evolve slowly over days.” Read full story Source: Independent Ireland, 13 September 2022 hub resources on sepsis RCNi: Sepsis resource collection NSW Clinical Excellence Commission - Sepsis toolkit Dr Ron Daniels video: Recognising sepsis Introducing the Suspicion of Sepsis Insights Dashboard
  11. News Article
    Liz Truss has received a stark insight into the dire state of the NHS after new figures showed millions of people in England were facing often record delays to access vital healthcare. One leading NHS expert said the long waits for care, diagnostic tests and hospital beds showed that Britain’s new prime minister “inherits an NHS in critical condition”. The total number of people in England waiting for hospital treatment rose again to a record high of 6.8 million at the end of July – almost one in eight of the population. Patients are also facing long waits for accident and emergency care, cancer treatment, such as surgery or chemotherapy, and for an ambulance to arrive after a 999 call. Of the 6.8 million people on NHS England’s “referral to treatment” waiting list, 2,665,004 had been waiting for more than 18 weeks, which is the supposed maximum waiting time for procedures such as a joint replacement, hernia repair or cataract removal. In addition, 377,689 had been waiting more than a year to start their treatment, almost 22,000 more than a month before, according to the latest monthly performance data published by NHS England. The data showed that ministers and NHS bosses had failed to fulfil their pledge to eradicate two-year waits by the end of July; 2,885 such cases had not been resolved by then, despite major efforts by hospitals to meet the target. Read full story Source: The Guardian, 8 September 2022
  12. News Article
    The backlog of urgent cancer referral patients who have waited 104 days or more for treatment has increased month-on-month again, internal NHS data reveals. Data obtained by HSJ shows the total backlog of NHS patients waiting over three months for their first treatment since referral grew by 10% month-on-month, from 10,361 as of 26 June, to 11,212 by 28 August. There are now nearly 341,000 patients are waiting to start their cancer treatment after being referred, the internal data also reveals. Under current NHS rules, the 104-day point marks a “backstop” – beyond which any patient waiting longer than this for treatment should be reviewed for potential harm. The NHS has not achieved this target since 2014. Read full story (paywalled) Source: HSJ, 7 September 2022
  13. News Article
    Excess deaths in the UK have continued to soar, as Covid deaths decreased for fourth week in a row, the latest data shows. A total of 10,942 deaths from all causes were registered in England and Wales in the week to 26 August, according to the Office for National Statistics. This is 16.6%above the five-year average, the equivalent of 1,556 “excess deaths” during this week. However, new figures show a continued downward trend in deaths involving Covid-19, which have fallen to the lowest level since the beginning of July. A total of 453 deaths registered in the seven days to August 26 mentioned coronavirus on the death certificate, according to the Office for National Statistics (ONS) – down 18 per cent on the previous week. Stuart Macdonald, from the Covid-19 actuaries’ response group, wrote: “There have been around 5,300 deaths with Covid-19 mentioned on the death certificate in the last ten weeks. Covid was the underlying cause for 3,400 of these and may also have contributed to others. Since Covid does not explain all the recent excess we need to look at other causes.” Mr Macdonald outlined a number of potential drivers of excess deaths which included increased risk of heart failure in people following Covid-19 infection, delays for urgent treatment within the NHS and missed or delayed diagnoses earlier in the pandemic. Read full story Source: The Independent, 6 September 2022
  14. News Article
    Ongoing research underway at The University of Queensland in Australia is focusing on stopping children undergoing chemotherapy from feeling pain and other debilitating side effects. Dr Hana Starobova from UQ’s Institute for Molecular Bioscience has been awarded a Fellowship Grant from the Children’s Hospital Foundation to continue her research to relieve children from the side effects of cancer treatments. “Although children have a higher survival rate than adults following cancer treatments, they can still be suffering side-effects well into their adulthood,” Dr Starobova said. “A five-year-old cancer patient could be suffering severe pain, gastrointestinal problems or difficulty walking 20 years on from treatment. “There has been a lack of studies on children, which is an issue because they are not just small adults — they suffer from different cancers, their immune systems work differently and they have a faster metabolism, all of which affect how treatments work. “Our aim is to treat children before the damage happens so that the side-effects are dramatically reduced or don’t occur in the first place.” Dr Starobova is currently analysing how specific drugs could prevent a cascade of inflammation caused by chemotherapy drugs, which lead to tingling and numbness in hands and feet, and muscle pain and weakness that makes everyday tasks, like walking and doing up buttons, a challenge. She is focusing on Acute lymphoblastic leukaemia, one of the most frequently diagnosed cancers in children, with over 700 children diagnosed in Australia each year. “We are studying the most commonly used chemotherapy treatment for children, which is a mix of drugs that are very toxic, but have to be used to treat cancer fast and stop it becoming resistant to the drugs,” Dr Starobova said. “It’s a fine balance — too little chemotherapy and cancer won’t be killed but sometimes the side effects are so bad, patients have to stop the therapy. “I hope that by having a treatment to reduce side-effects, it will be one less thing for these kids and their families to worry about.” Read full story Source: The Print, 15 August 2022
  15. News Article
    There is an urgent need to develop evidence based clinical guidelines for managing cases of monkeypox, scientists said, after finding that existing guidance frequently lacked detail and was based on poor research. They urged establishing a 'living guideline' for infectious disease to ensure that up-to-date information, based on robust research, was available globally and in any setting. The study, published in BMJ Global Health, also called for investment to back research into optimal treatments and prophylaxis strategies. The study authors wrote: "The lack of clarity between guidelines creates uncertainty for clinicians treating patients with MPX [monkeypox] which may impact patient care." They concluded: "Our study highlights a need for a rigorous framework for producing guidelines ahead of epidemics and a recognised platform for rapidly reviewing and updating guidance during outbreaks, as new evidence emerges." Current global concern over the spread of monkeypox was an opportune time to act, they argued. Read full story Source: Medscape, 17 August 2022
  16. News Article
    A new report by the Stroke Association released today warns that, if the thrombectomy rate stays at 2020/21 levels, 47,112 stroke patients in England would miss out on the game changing acute stroke treatment, mechanical thrombectomy, over the length of the newly revised NHS Long Term Plan. This year, NHS England missed its original target to make mechanical thrombectomy available to all patients for whom it would benefit – only delivering to 28% of all suitable patients by December 20212. The Stroke Association’s ‘Saving Brains’ report calls for a 24/7 thrombectomy service, which could cost up to £400 million. But treating all suitable strokes with thrombectomy would save the NHS £73 million per year. Stroke professionals quoted in the report cite insufficient bi-plane suites, containing radiology equipment, as a barrier to a 24/7 service. The Stroke Association is calling for: The Treasury to provide urgent funding for thrombectomy in the Autumn Budget 2022, for infrastructure, equipment, workforce training and support, targeting both thrombectomy centres and referring stroke units. Department of Health and Social Care to develop a sustainable workforce plan to fill the gaps in qualified staff. NHS England to address challenges in transfer to and between hospitals in its upcoming Urgent & Emergency Care Plan. Putting innovation - such as artificial intelligence (AI) imaging software and video triage in ambulances - into practice. Juliet Bouverie, Chief Executive of the Stroke Association said: “Thrombectomy is a miracle treatment that pulls patients back from near-death and alleviates the worst effects of stroke. It’s shocking that so many patients are missing out and being saddled with unnecessary disability. Plus, the lack of understanding from government, the NHS and local health leaders about the brain saving potential thrombectomy is putting lives at risk. There are hard-working clinicians across the stroke pathway facing an uphill struggle to provide this treatment and it’s time they got the support they need to make this happen. It really is simple. Thrombectomy saves brains, saves money and changes lives; now is the time for real action, so that nobody has to live with avoidable disability ever again." Read full story Source: The Stroke Association, 28 July 2022
  17. News Article
    One of the NHS’s biggest hospital trusts has declared its cancer waiting list is now at an ‘unmanageable size’. Mid and South Essex Foundation Trust leaders set out the stark judgement in a paper for its July board meeting, held last week. The report said: “The 62-day [referral to treatment backlog as of 3 July] has increased for the second consecutive week to 1,055. “[The cancer patient tracking list] is getting bigger and has reached an unmanageable size. Referral rates have plateaued from March 2021 [but] treatment rates have not increased in line with PTL growth. “This points to a noisy PTL, where the hospital is extremely busy managing patients who do not have cancer.” The paper also said NHS England had recognised the trust’s 62-day cancer target needed to be delivered “in more realistic and achievable stages”. It highlighted particular concerns around a “serious” demand and capacity problem in its dermatology department which contributed to almost half of its 62-day backlog. The trust had 445 62-day RTT cancer breaches in dermatology alone in May, the latest data reported. Read full story (paywalled) Source: HSJ, 22 July 2022
  18. News Article
    A cross-party group of MPs and peers have written to the health secretary requesting an “urgent” meeting to discuss “unregulated” and “untested” treatments that are being offered to Long Covid patients in the UK. It comes after The Independent uncovered a wide range of unproven and “dangerous” therapies being touted to patients, few of which have been approved for use in the NHS – or rigorously tested – for alleviating persistent coronavirus symptoms. Patients with Long Covid are also travelling abroad to clinics in Europe to receive treatments such as “blood washing”, often at a cost of tens of thousands of pounds, according to an ITV and BMJ investigation. In a letter to health secretary Steve Barclay, the All-Party Parliamentary Group on Coronavirus expressed concern that patients “desperately” awaiting treatment through the NHS are being exploited by private clinics, and urged the government to launch an investigation into the provision of unproven care. The group wrote: “It has come to the attention of the APPG that a number of unregulated long Covid clinics are operating in the UK, offering untested and unscientific treatments to people living with long Covid. “The evidence our parliamentary group has heard makes it clear that in some parts of the country the current NHS long Covid care pathways are unfit for purpose, with access to NHS long Covid clinics being described as a ‘postcode lottery’.” Read full story Source: The Independent, 14 July 2022
  19. News Article
    Paul Pettinger’s trip to Cyprus came because he felt the NHS had no treatments to offer him. Paul got Covid in the first wave in 2020. After the initial illness, he was left with extreme tiredness and 10% of the energy he once had. “I have a very small amount of energy and when I use up my energy, I end up with headaches, brain fog and with cognitive issues. It's very hard to think. And also I can't walk very far,” he says. His life then fell apart and he lost his job. “I have been almost housebound for over two years.” he says adding: “I’ve become a burden on family and friends.” A joint investigation between ITV News and the BMJ has found that Paul is 1 of around 120 people with Long Covid symptoms who have travelled to Cyprus for treatment. But thousands more have had the treatment in countries spending life changing sums of money. The Long Covid Center is one of several private clinics offering this treatment - others are in Germany and Switzerland. This is Paul’s seventh session. And, he says, he notices a difference and has confidence in the process. “After each treatment, I experienced a small improvement,” he says. “It is the only treatment out there at the time being and so far it's working.” However, experts have raised concerns over whether such invasive and expensive therapies should be offered without sufficient evidence. “I am worried these patients have been offered therapies which have not been assessed by modern scientific methods – well-designed clinical trials,” said Beverley Hunt, medical director of the charity Thrombosis UK. “In this situation, the treatment may or may not benefit them but, worryingly, also has the risk of harm.” Read full story Source: ITV News, 12 July 2022
  20. News Article
    The Scottish government has signed a contract to allow NHS patients to visit a US expert for mesh removal surgery. Patients can book appointments with Dr Dionysios Veronikis in Missouri with their travel and accommodation costs paid for by the NHS. The cost of each procedure is estimated to be £16,000 to £23,000. Transvaginal implant use was stopped in Scotland after hundreds of women were left with painful, life-changing side effects. NHS National Services Scotland said it would work with NHS Greater Glasgow and Clyde and local health boards to take forward arrangements for those who wish to travel to the US for the procedure. Health Secretary Humza Yousaf said: "I fully understand that women want mesh removal surgery undertaken by surgeons who enjoy their full confidence and a range of measures are now in place to ensure this happens. "I am determined to ensure that those with mesh complications get the treatment they want and need." Read full story Source: BBC News, 12 July 2022
  21. News Article
    Emma Hardy MP has secured a Westminster debate on gynaecological wait times. Gynaecology waiting lists across the UK have now reached a combined figure of more than 610,000 – a 69% increase on pre-pandemic levels. New analysis by the Royal College of Obstetricians and Gynaecologists (RCOG) shows that in England, gynaecology waiting lists have grown the most by percentage increase of all elective specialties. Emma is co-chair of the All Party Parliamentary Groups (APPGs) for Surgical Mesh and Endometriosis - both come under the heading of ‘gynaecological conditions’ and both are being impacted by increased waiting times. Through her involvement with these APPGs, Emma has heard the testimony of so many women whose lives have been impacted by conditions that can be so painful and debilitating that they impact on every aspect of family, social and work life. Emma will ask the minister to launch an investigation into possible gender bias in the prioritisation of gynaecology services and ensure that elective recovery will address the unequal growth of gynaecology waiting lists compared to other specialties. Emma said: "It is completely unacceptable that 610,000 women are waiting for gynaecological care across the UK. The reality is that many of these women will be in excruciating pain awaiting treatment, unable to go about their day-to-day lives." Read full story Source: Hull Daily Mail, 5 July 2022
  22. News Article
    The UK must urgently procure stocks of a drug that can boost vulnerable people’s protection against Covid, experts have urged in a letter to The Times. Evusheld, made by AstraZeneca, was licensed by the UK regulator the Medicines and Healthcare products Regulatory Agency in March. Some people with immune system problems, such as blood cancer patients or organ transplant patients do not get sufficient protection from vaccinations and many are continuing to shield. Campaigners believe that offering Evusheld to those people could allow them to resume normal life. Evusheld is being used in countries including the United States and Israel but the UK government has yet to ask AstraZeneca for supplies. In a letter published in The Times, Gemma Peters, chief executive of Blood Cancer UK, and Lord Mendelsohn, co-chairman of the All-Party Parliamentary Group on Vulnerable Groups to Pandemics, say that this represents a failure of a promise made at the start of the pandemic that the government would “do everything in its power to protect the vulnerable”. They write: “People who are immunocompromised are still dying from Covid at much higher rates than the rest of the population. They cannot afford to wait. They deserve better.” Read full story (paywalled) Source: The Times, 6 July 2022
  23. News Article
    The NHS plans to use drones to fly chemotherapy drugs to cancer patients in England to avoid the need for long journeys to collect them. The devices will transport doses from Portsmouth to the Isle of Wight in a trial that, if successful, will lead to drones being used for similar drops elsewhere. They will take 30 minutes to travel acrss the Solent, which will save patients on the island a three to four-hour round trip by ferry or hovercraft. On Tuesday, Amanda Pritchard, NHS England’s chief executive, unveiled the move to help mark the 74th anniversary of the health service’s creation by the postwar Labour government. “Delivering chemo by drone is another extraordinary development for cancer patients and shows how the NHS will stop at nothing to ensure people get the treatment they need as promptly as possible, while also cutting costs and carbon emissions,” she said. Read full story Source: The Guardian, 5 July 2022
  24. News Article
    The NHS is wasting time and money due to a ‘culture of overtreatment’ in cancer care, a report has revealed. An All-Party Parliamentary Group paper released on Tuesday on minimally invasive cancer treatments (MICTs) found only 10 per cent of cancer patients are offered non-invasive treatments. This is despite many of these treatments being recommended by the National Institute for Health and Care Excellence (NICE). And many doctors and patients remain in the dark about some of the newer treatments due to ‘a severe lack of education’ . The APPG, which is made up of different political parties and peers, was formed to drive awareness of Minimally Invasive Cancer Therapies - proven cancer treatments that provide similar outcomes to cancer surgery but are more targeted and less invasive than traditional surgery. Paul Sayer, founder of charity Prost8, which launched its ‘ONE in EIGHT’ campaign to help men with prostate cancer get better access to minimally invasive treatment, said: “The report has identified a culture of overtreatment even when it’s not the best or safest option. Read full story Source: The Independent, 29 June 2022
  25. News Article
    Thousands of women in England with mental health problems are being given electric shock treatment despite concerns the therapy can cause irreparable brain damage. NHS data seen by The Independent reveals the scale of electroconvulsive therapy (ECT) prescribed disproportionately to women, who make up two-thirds of patients receiving the treatment. Health professionals have warned the therapy can cause brain damage so severe recipients are unable to recognise family and friends or do basic maths. While some patients say the therapy profoundly helped them, leading mental charities have branded it “damaging” and “outdated” and called for its use to be halted pending an urgent review or banned entirely. Statistics obtained through Freedom of Information requests by Dr John Read, a professor at the University of East London and leading expert on ECT, showed 67% of 1,964 patients who received the treatment in 2019 were female. ECT was given to women twice as often as men across 20 NHS trusts in the UK, his research found. The trusts also said some 36% of their patients in 2019 underwent ECT without providing consent. A spokesperson added patients should be fully informed of the risks associated with ECT and the decision to deploy the treatment “should be made jointly with the person with depression as far as possible”. Read full story Source: The Independent, 19 June 2022
×
×
  • Create New...